Clinical Trial

PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This phase II randomized trial evaluates PD-1 inhibitor plus chemotherapy followed by immediate versus selective re-irradiation in locally advanced recurrent nasopharyngeal carcinoma. The study aims to determine whether sequential radiotherapy provides additional survival benefit beyond systemic immunochemotherapy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-09.
Status change: Not Yet Recruiting → Recruiting 2026-02-02
Trial Details
NCT Number NCT07332247
Lead Sponsor Sun Yat-sen University
Conditions Nasopharangeal Cancer, Recurrent Nasopharynx Carcinoma
Enrollment 94 participants
Start Date 2026-02-03
Primary Completion 2032-02-03 (estimated)
Study Completion 2035-02-03 (estimated)
Updated on ClinicalTrials.gov 2026-02-04